RFID tracking and privacy workshop
Executive Summary
Emerging uses of radiofrequency identification technology and implications for consumer protection is the subject of a Sept. 23 workshop being convened by Federal Trade Commission staff. The session will bring together industry, government and consumer representatives from Europe and the U.S. to discuss security and privacy concerns associated with RFID. The technology is seen by some drug makers as having the potential to increase security of the pharmaceutical supply chain, and the growing utilization of item-level tagging in the retail sector is on the agenda (1"The Pink Sheet," June 16, 2008, p. 16)
You may also be interested in...
RFID’s Possible Interaction With Biologics Queried By Biogen, Pfizer
Radiofrequency identification appears to hold the most potential to increase the security of the pharmaceutical supply chain, stakeholders advise FDA, but important questions include how the radiofrequency emissions might interact with biologics and certain other kinds of drug products
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.